Because androgen-independent prostate cancers often become resistant to antiandrogens and AR mutations can result in stimulation by other steroids, including antiandrogens, we tested the effect of the antiandrogen flutamide on DHT-stimulated growth in control and CAsE-PE cells. The gene discussed is AR; the disease is prostate cancer.